Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Diversified Energy delivers 'solid' FY24 performance

(Sharecast News) - Gas and oil production company Diversified Energy said on Tuesday that its FY24 performance had been "solid" and highlighted stable production levels, strong cash flows, and its continued expansion. Diversified Energy said it produced an average of 132,000 barrels of oil equivalent per day in FY24, with Q4 rates reaching 141,000 boepd.

The FTSE 250-listed firm stated it now expects to report adjusted underlying earnings of $470.0m-475.0m, while adjusted free cash flow was pegged to be between $210.0m and $215.0m.

Chief executive Rusty Hutson said: "Our strong results highlight our unique business model that strives to deliver consistent cash flow during the full range and volatility of commodity cycles

"We are optimistic about our future and confident that our current efforts will continue to position us well to have a significant positive impact on shareholder value."

Elsewhere, Diversified Energy also announced its $1.3bn acquisition of Maverick Natural Resources, a move it said added immediate scale, increased liquids production, and created a combined company with long-term free cash flow generation, superior unit cash margins, and a compelling sustainability profile.

As of 0930 GMT, Diversified Energy shares were untraded at 1,366.0p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.